Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › CA › Pleasanton › NPI 1144389941
Hospital

Stanford Health Care Tri-Valley

Stanford Health Care Tri-Valley was paid $15.90M by Medicaid between Jan 2018 and Dec 2024, across 206 billing codes. Its largest line is 87637, Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV — 11% of everything it billed.

33Billing provider infoSTANFORD HEALTH CARE TRI-VALLEY
PLEASANTON, CA 94588
33aNPI1144389941assigned 12/07/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$15.90M
24GClaims411,795
24DCodes billed206
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other General Acute Care Hospital providers in California

Rank by total paid#140 of 410
Median peer was paid$6.90M
This provider vs. median2.3×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$200K$400K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
201849,201$1.41M
201951,377$1.48M
202038,483$1.33M
202153,538$2.02M
202264,614$2.85M
202371,332$2.99M
2024incomplete83,250$3.83M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
87637 Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV 11% 7,362 7,211 $1.70M
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 9.5% 31,962 28,379 $1.51M
74177 Computed tomography, abdomen and pelvis; with contrast material 5.9% 2,800 2,746 $944K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance 5.8% 8,888 8,243 $920K
99070 5.1% 30,454 14,238 $813K
99231 Subsequent hospital care, per day, straightforward or low complexity 4.2% 28,495 25,117 $671K
96375 Therapeutic injection; each additional sequential IV push 3.4% 6,997 6,240 $548K
0450 Emergency room services 3.4% 9,573 8,616 $535K
J3490 Unclassified drugs 2.8% 24,568 11,214 $448K
70450 Computed tomography, head or brain; without contrast material 2.5% 2,942 2,861 $405K
U0004 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r 2.3% 4,641 4,321 $358K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report 2.1% 10,153 9,399 $338K
194 more codes
80053 Comprehensive metabolic panel 2.1% 18,846 $337K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour 2.1% 2,296 $330K
96361 Intravenous infusion, hydration; each additional hour 1.7% 3,434 $275K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular 1.7% 5,008 $266K
87636 Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B 1.6% 1,173 $248K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 1.5% 24,218 $236K
99199 Unlisted special service, procedure or report 1.5% 5,315 $233K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed 1.2% 2,725 $183K
71045 Radiologic examination, chest; single view 1.1% 7,445 $171K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 1.0% 2,338 $164K
74176 Computed tomography, abdomen and pelvis; without contrast material 1.0% 890 $163K
84484 <1% 7,624 $156K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay <1% 1,900 $146K
71275 Computed tomographic angiography, chest, with contrast material <1% 486 $141K
99283 Emergency room visit (moderate) <1% 429 $134K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe <1% 2,509 $131K
80048 Basic metabolic panel (calcium, ionized) <1% 7,943 $116K
0250 <1% 4,526 $114K
71046 Radiologic examination, chest; 2 views <1% 3,381 $111K
59025 Fetal non-stress test <1% 3,550 $96K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 4,511 $88K
99285 Emergency room visit (most serious) <1% 98 $84K
83880 <1% 2,314 $84K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 1,651 $82K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 1,650 $82K
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 5,415 $79K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 2,823 $76K
T1999 Miscellaneous therapeutic items and supplies, retail purchases, not otherwise classified; identify product in "remarks" <1% 4,254 $75K
87088 <1% 6,511 $75K
76705 Ultrasound, abdominal, real time with image documentation; limited <1% 982 $75K
78815 Positron emission tomography (PET) for limited area imaging <1% 65 $73K
C9803 Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source <1% 3,356 $70K
83690 <1% 6,687 $70K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour <1% 522 $61K
92507 Treatment of speech, language, voice, communication, and/or auditory processing disorder <1% 1,143 $61K
72125 Computed tomography, cervical spine; without contrast material <1% 345 $58K
84443 Thyroid stimulating hormone (TSH) <1% 2,584 $57K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete <1% 263 $53K
87631 <1% 598 $53K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets <1% 486 $49K
93971 <1% 399 $48K
87040 <1% 1,866 $43K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete <1% 504 $43K
0516 <1% 1,706 $41K
81001 <1% 8,961 $41K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 500 $39K
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 4,424 $38K
Z7502 <1% 1,091 $37K
0456 <1% 1,123 $37K
70498 <1% 145 $36K
70496 <1% 118 $36K
83735 <1% 3,592 $36K
87634 <1% 450 $35K
73562 <1% 1,180 $35K
73610 <1% 1,058 $35K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion <1% 2,761 $33K
99281 Emergency department visit for the evaluation and management, self-limited or minor <1% 582 $31K
84703 <1% 2,810 $31K
73630 <1% 917 $30K
97140 Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) <1% 1,649 $30K
76815 Ultrasound, pregnant uterus, real time with image documentation, limited <1% 367 $29K
82553 <1% 1,882 $29K
0002A <1% 709 $28K
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 903 $28K
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour <1% 136 $27K
76830 Ultrasound, transvaginal <1% 320 $27K
85379 <1% 1,745 $25K
Q3014 Telehealth originating site facility fee <1% 1,296 $24K
87186 <1% 2,147 $23K
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 1,108 $22K
85027 <1% 3,031 $21K
0001A <1% 714 $21K
82962 <1% 3,644 $21K
83605 <1% 1,466 $19K
J1170 Injection, hydromorphone, up to 4 mg <1% 2,059 $18K
76801 <1% 166 $18K
J0134 Injection, acetaminophen (fresenius kabi), not therapeutically equivalent to j0131, 10 mg <1% 94 $17K
93458 <1% 13 $17K
96413 Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance <1% 106 $16K
90715 <1% 249 $15K
99218 <1% 100 $14K
36415 Collection of venous blood by venipuncture <1% 1,712 $14K
J2270 Injection, morphine sulfate, up to 10 mg <1% 1,643 $13K
73030 <1% 420 $13K
Z7610 <1% 960 $13K
87070 <1% 891 $10K
76817 Ultrasound, pregnant uterus, real time with image documentation, transvaginal <1% 102 $10K
87077 <1% 1,081 $10K
85610 <1% 2,029 $9K
96367 <1% 119 $9K
94760 <1% 788 $9K
97530 Therapeutic activities, direct patient contact, each 15 minutes <1% 429 $8K
J2060 Injection, lorazepam, 2 mg <1% 1,320 $8K
86900 <1% 1,205 $8K
0270 <1% 1,370 $7K
81003 <1% 2,632 $7K
73110 <1% 233 $7K
72100 <1% 230 $7K
83036 Hemoglobin; glycosylated (A1C) <1% 718 $7K
73130 <1% 175 $7K
85730 <1% 996 $7K
G0447 Face-to-face behavioral counseling for obesity, 15 minutes <1% 191 $6K
81025 <1% 1,205 $6K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 558 $6K
80061 Lipid panel <1% 336 $5K
86901 <1% 1,483 $5K
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 939 $5K
66984 Extracapsular cataract removal with insertion of intraocular lens prosthesis <1% 14 $5K
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) <1% 847 $5K
J1815 Injection, insulin, per 5 units <1% 33 $5K
87210 <1% 807 $5K
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc <1% 82 $4K
71250 <1% 52 $4K
99232 Hospital visit by a doctor, follow-up day <1% 19 $4K
86850 <1% 1,036 $4K
V2632 Posterior chamber intraocular lens <1% 35 $4K
70551 Magnetic resonance imaging, brain; without contrast material <1% 24 $4K
J2272 Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg <1% 332 $4K
71260 Computed tomography, thorax, diagnostic; with contrast material <1% 26 $4K
Z7500 <1% 106 $3K
A9552 Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries <1% 28 $3K
J2001 Injection, lidocaine hcl for intravenous infusion, 10 mg <1% 158 $3K
94644 <1% 92 $3K
76805 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation <1% 27 $3K
J2765 Injection, metoclopramide hcl, up to 10 mg <1% 494 $3K
74018 <1% 93 $3K
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 338 $3K
J0131 Injection, acetaminophen, not otherwise specified,10 mg <1% 14 $3K
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity <1% 112 $3K
87430 <1% 220 $3K
82248 <1% 359 $3K
93017 <1% 26 $2K
73140 <1% 82 $2K
0003A <1% 49 $2K
86140 <1% 269 $2K
84439 <1% 166 $2K
J2919 Injection, methylprednisolone sodium succinate, 5 mg <1% 17 $2K
70486 <1% 13 $2K
73502 <1% 40 $2K
J2003 Injection, lidocaine hydrochloride, 1 mg <1% 36 $2K
J1171 Injection, hydromorphone, 0.1 mg <1% 41 $2K
97750 <1% 75 $2K
84702 <1% 98 $2K
71020 <1% 44 $1K
99152 <1% 45 $1K
97139 <1% 70 $1K
82803 <1% 65 $1K
71101 <1% 40 $1K
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism <1% 25 $1K
Q9966 Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml <1% 36 $976.00
G0463 Hospital outpatient clinic visit for assessment and management of a patient <1% 14 $938.50
85007 <1% 289 $909.47
73080 <1% 25 $863.57
86780 <1% 40 $852.73
0012A <1% 30 $851.70
81002 <1% 161 $820.51
0761 <1% 31 $748.42
A9577 Injection, gadobenate dimeglumine (multihance), per ml <1% 15 $718.34
83540 <1% 85 $714.95
83520 <1% 51 $701.15
0011A <1% 40 $677.60
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 103 $676.82
0051A <1% 16 $640.00
85652 <1% 143 $637.99
97112 Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination <1% 66 $592.39
J3010 Injection, fentanyl citrate, 0.1 mg <1% 86 $559.79
80299 <1% 31 $554.62
83550 <1% 70 $515.16
87641 <1% 27 $500.65
0760 <1% 36 $490.84
0064A <1% 12 $480.00
G1004 Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program <1% 293 $459.83
96376 <1% 14 $459.78
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 12 $424.86
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed <1% 13 $414.40
71010 <1% 20 $394.44
82948 <1% 87 $387.25
94729 <1% 13 $373.05
87205 <1% 78 $356.58
29125 <1% 13 $351.68
J0780 Injection, prochlorperazine, up to 10 mg <1% 26 $280.84
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg <1% 26 $257.07
87340 <1% 12 $193.69
82550 <1% 31 $179.42
J1650 Injection, enoxaparin sodium, 10 mg <1% 15 $178.38
82728 <1% 14 $176.28
84100 <1% 44 $134.80
Q0162 Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen <1% 16 $107.16
J7512 Prednisone, immediate release or delayed release, oral, 1 mg <1% 17 $106.60
86308 <1% 13 $75.39
J0136 Injection, acetaminophen (b braun), not therapeutically equivalent to j0131, 10 mg <1% 16 $55.38
J2704 Injection, propofol, 10 mg <1% 14 $44.32
J7620 Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme 0% 16 $0.00
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 0% 51 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialWICHELMANN, KYLE (CHIEF FINANCIAL OFFICER)